SMA-560 Mouse Orthotopic Glioma Cell Line

The SMA-560 cell line is a well-established glioma model derived from a spontaneous murine astrocytoma (2,3). SMA560 cells are highly reflective of differentiated anaplastic astrocytoma, having high expression of the differentiated astrocyte marker glial fibrillary acid protein (GFAP) and the astrocyte marker glutamine synthetase and low expression of S-100 proteins (4,5). The SMA560 cell line maintains robust tumorigenic behavior after serial passaging (2). Uniquely among established murine glioma models, SMA560 cells express the immunosuppressive protein transforming growth factor β (TGF-β) (6), making this cell line of great value for investigation of targeted cancer immunotherapies.

Source:
SMA-560 cell line was derived from a spontaneous astrocytoma passaged in syngenic VM/Dk mice (2).

Gliomas are a rare and aggressive cancer with an extremely low survival rate and high resistance to treatment (1). Glioma models that recapitulate the multiple features of the disease are important for understanding of mechanisms of glioma malignancy and development of effective therapies, especially those that address tumor-induced immunosuppression and resistance.

References:
1. N Engl J Med 2005; 352(10): 987-996.
2. Acta Neuropathol 1980; 51(1): 53-64.
3. Neurosci Lett 1982; 34(3): 315-320.
4. J Neurol Sci 1983; 62(1-3): 115-139.
5. J Neurol Neurosurg Psychiatry 1986; 49(12): 1361-1366.
6. Neurosurgery 1997; 41(6): 1365-1372.

SMA-560 cell line is a well-established glioma model derived from a spontaneous murine astrocytoma.

Cancer Cells

≥1X10^⁶ cells/vial

Store in liquid nitrogen. The cells can be cultured for at least 10 passages after initial thawing without significantly affecting the cell marker expression and functionality.

Subject to local law, this product is intended to be sold for internal in vitro research use only subject to terms and conditions found here: www.sigmaaldrich.com/restrictedcelluse. This product may not be: re-engineered or copied; used to make derivatives, modifications or functional equivalents; used to obtain patents or other IP claiming use of the product; used to develop, test, or manufacturer a commercial product; used as a component in a commercial product; resold or licensed; used in any clinical applications or trials; or used in humans. A license or limited commercial use agreement is required for use by any for-profit entity, use in services, and use in sponsored academic research. For information regarding any such use, please contact licensing@milliporesigma.com.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.